BRPI0416898A - dispositivos de filtragem de fluxo tangencial e métodos para o enriquecimento de células-tronco - Google Patents

dispositivos de filtragem de fluxo tangencial e métodos para o enriquecimento de células-tronco

Info

Publication number
BRPI0416898A
BRPI0416898A BRPI0416898-4A BRPI0416898A BRPI0416898A BR PI0416898 A BRPI0416898 A BR PI0416898A BR PI0416898 A BRPI0416898 A BR PI0416898A BR PI0416898 A BRPI0416898 A BR PI0416898A
Authority
BR
Brazil
Prior art keywords
tangential flow
stem cell
methods
flow filtering
filtering devices
Prior art date
Application number
BRPI0416898-4A
Other languages
English (en)
Inventor
Marnix L Bosch
Patricia A Lodge
Julle Anna Mcearchern
Alton L Boynton
Paul G Hugenholtz
Original Assignee
Northwest Biotherapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Northwest Biotherapeutics Inc filed Critical Northwest Biotherapeutics Inc
Publication of BRPI0416898A publication Critical patent/BRPI0416898A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0662—Stem cells
    • C12N5/0663—Bone marrow mesenchymal stem cells (BM-MSC)
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D35/00—Filtering devices having features not specifically covered by groups B01D24/00 - B01D33/00, or for applications not specifically covered by groups B01D24/00 - B01D33/00; Auxiliary devices for filtration; Filter housing constructions
    • B01D35/05—Floating filters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C12N5/0647—Haematopoietic stem cells; Uncommitted or multipotent progenitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K2035/124—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells the cells being hematopoietic, bone marrow derived or blood cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/30—Organic components
    • C12N2500/35—Polyols, e.g. glycerin, inositol
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/25—Chemistry: analytical and immunological testing including sample preparation
    • Y10T436/25375—Liberation or purification of sample or separation of material from a sample [e.g., filtering, centrifuging, etc.]
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/25—Chemistry: analytical and immunological testing including sample preparation
    • Y10T436/25375—Liberation or purification of sample or separation of material from a sample [e.g., filtering, centrifuging, etc.]
    • Y10T436/255—Liberation or purification of sample or separation of material from a sample [e.g., filtering, centrifuging, etc.] including use of a solid sorbent, semipermeable membrane, or liquid extraction

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Developmental Biology & Embryology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Cardiology (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Cell Biology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Water Supply & Treatment (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)

Abstract

"DISPOSITIVOS DE FILTRAGEM DE FLUXO TANGENCIAL E MéTODOS PARA O ENRIQUECIMENTO DE CéLULAS-TRONCO". A presente invenção proporciona métodos para enriquecer uma mistura heterogênea de medula óssea ou de constituintes do sangue com relação a células-tronco, através da remoção de constituintes que não as células-tronco, compreendendo a separação dos constituintes que não as células-tronco com a utilização de um dispositivo de filtragem de fluxo tangencial.
BRPI0416898-4A 2003-11-24 2004-11-19 dispositivos de filtragem de fluxo tangencial e métodos para o enriquecimento de células-tronco BRPI0416898A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US52451103P 2003-11-24 2003-11-24
PCT/US2004/038805 WO2005052137A1 (en) 2003-11-24 2004-11-19 Tangential flow filtration devices and methods for stem cell enrichment

Publications (1)

Publication Number Publication Date
BRPI0416898A true BRPI0416898A (pt) 2007-03-06

Family

ID=34632903

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0416898-4A BRPI0416898A (pt) 2003-11-24 2004-11-19 dispositivos de filtragem de fluxo tangencial e métodos para o enriquecimento de células-tronco

Country Status (14)

Country Link
US (1) US7790039B2 (pt)
EP (1) EP1689855A4 (pt)
JP (2) JP2007512814A (pt)
KR (1) KR20070055416A (pt)
CN (2) CN102321573B (pt)
AR (1) AR047043A1 (pt)
AU (1) AU2004293794B2 (pt)
BR (1) BRPI0416898A (pt)
CA (1) CA2546349C (pt)
CR (1) CR8414A (pt)
IL (1) IL175530A (pt)
RU (1) RU2006122038A (pt)
TW (1) TWI354572B (pt)
WO (1) WO2005052137A1 (pt)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8273253B2 (en) 2007-03-02 2012-09-25 Smith & Nephew Plc Apparatus and method for filter cleaning by ultrasound, backwashing and filter movement during the filtration of biological samples
CN101801431B (zh) * 2007-06-22 2014-11-19 循环生物制品有限责任公司 流体浓缩器和自体浓缩体液及其使用方法
KR100867942B1 (ko) * 2007-08-09 2008-11-10 콘티넨탈 오토모티브 일렉트로닉스 주식회사 차량용 에이비에스 센서의 리드프레임 구조
JP5330996B2 (ja) * 2007-08-23 2013-10-30 国立大学法人 新潟大学 ヒト骨膜培養方法
FR2931081B1 (fr) * 2008-05-14 2010-06-25 Direction Et Pirorites Dispositif de filtration d'un liquide complexe tel que du sang, notamment applicable a un autotransfuseur
US8546127B2 (en) * 2008-06-30 2013-10-01 General Electric Company Bacteria/RNA extraction device
AU2009275287B2 (en) 2008-07-25 2015-07-23 Smith & Nephew Plc Controller for an acoustic standing wave generation device in order to prevent clogging of a filter
WO2010114136A1 (ja) * 2009-03-30 2010-10-07 第一三共株式会社 多能性幹細胞及び心筋細胞以外の分化細胞に対する細胞死誘導方法
US20100291534A1 (en) * 2009-05-12 2010-11-18 National Central University Methods and Systems for Isolating, Ex Vivo Expanding and Harvesting Hematopoietic Stem Cells
DK3150701T3 (en) 2009-06-05 2019-01-14 Fujifilm Cellular Dynamics Inc REPROGRAMMING T-CELLS AND HEMATOPOIETIC CELLS
AU2013204820B2 (en) * 2009-12-23 2014-01-30 Cytovera, Inc. A System and Method for Particle Filtration
SG181676A1 (en) * 2009-12-23 2012-07-30 Cytovera Inc A system and method for particle filtration
CN101851606B (zh) * 2010-04-07 2012-05-30 魏红江 卵丘-卵母细胞复合体刀切过滤法
CN102260628A (zh) * 2010-05-31 2011-11-30 上海康德莱企业发展集团医疗器械有限公司 一种干细胞过滤筛选富集并快速复合装置
JP2012080821A (ja) * 2010-10-12 2012-04-26 Univ Of Tsukuba 血液中の有核細胞成分濃縮方法
GB201106802D0 (en) * 2011-04-21 2011-06-01 Allergy Therapeutics Ltd Process for preparing vaccine composition
CN102212461B (zh) * 2011-05-05 2013-04-17 中国人民解放军第二炮兵总医院 间充质干细胞过滤分离器及其应用
WO2012174225A2 (en) * 2011-06-14 2012-12-20 The University Of North Carolina At Chapel Hill Isolation, expansion and use of autologous pluripotent stem cells
US10934519B2 (en) * 2011-07-29 2021-03-02 Global Life Sciences Solutions Usa Llc Systems, methods and control laws for cell harvesting
US9427512B2 (en) 2012-06-08 2016-08-30 Pall Corporation Filter device
US9421317B2 (en) 2012-06-08 2016-08-23 Pall Corporation Cell harvesting device and system
EP2931330A1 (en) * 2012-12-14 2015-10-21 BHC Technology Holdings LLC Point of care isolation and concentration of blood cells
SG11201408169YA (en) * 2012-12-14 2015-01-29 Chong Zheng Centrifugal dynamic filtering apparatus and cell separation system using same
EP2950811A4 (en) * 2013-02-01 2016-06-08 Ampio Pharmaceuticals Inc PROCESSES FOR PRODUCING DICETOPIPERAZINES AND COMPOSITIONS CONTAINING SAME
JP2016518415A (ja) * 2013-10-21 2016-06-23 アドバンスド ニューロリジェネレイティブ セラピーズ エルエルシー 加齢と疾患免疫機能障害と細胞老化とをリンパ球系幹細胞で修復する方法、及び治療使用のためのそれらの再適用する方法
US9968738B2 (en) 2014-03-24 2018-05-15 Fenwal, Inc. Biological fluid filters with molded frame and methods for making such filters
US9782707B2 (en) 2014-03-24 2017-10-10 Fenwal, Inc. Biological fluid filters having flexible walls and methods for making such filters
US10376627B2 (en) 2014-03-24 2019-08-13 Fenwal, Inc. Flexible biological fluid filters
US10159778B2 (en) 2014-03-24 2018-12-25 Fenwal, Inc. Biological fluid filters having flexible walls and methods for making such filters
US9796166B2 (en) 2014-03-24 2017-10-24 Fenwal, Inc. Flexible biological fluid filters
EP3650096A3 (en) * 2015-01-21 2020-07-29 Agency For Science, Technology And Research Column-based device and method for retrieval of rare cells based on size, and uses thereof
CN105713870A (zh) * 2016-03-04 2016-06-29 佰通生物技术(苏州)有限公司 一种基于集落刺激因子1对干细胞的活化方法
EP4360567A3 (en) * 2016-10-24 2024-07-31 Yale University Aspiration device
CN112342192B (zh) * 2020-10-27 2022-08-05 北京唐颐惠康生物医学技术有限公司 一种连续切向流干细胞分离纯化方法

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4240398A (en) * 1978-10-05 1980-12-23 Lindop Arthur H Cleaning device for cooker grills
US4420398A (en) 1981-08-13 1983-12-13 American National Red Cross Filteration method for cell produced antiviral substances
US4888115A (en) 1983-12-29 1989-12-19 Cuno, Incorporated Cross-flow filtration
DE3432718C1 (de) 1984-09-06 1986-05-22 Biotest Pharma GmbH, 6000 Frankfurt Verfahren zur Herstellung einer Loesung von Milch- und/oder Kolostralimmunglobulinen
GB2176715A (en) 1985-06-27 1987-01-07 Apv Int Ltd Beer filtration
US4722902A (en) * 1985-11-04 1988-02-02 Endotronics, Inc. Apparatus and method for culturing cells, removing waste and concentrating product
US5192553A (en) * 1987-11-12 1993-03-09 Biocyte Corporation Isolation and preservation of fetal and neonatal hematopoietic stem and progenitor cells of the blood and methods of therapeutic use
US5948441A (en) 1988-03-07 1999-09-07 The Liposome Company, Inc. Method for size separation of particles
US5423738A (en) 1992-03-13 1995-06-13 Robinson; Thomas C. Blood pumping and processing system
NL9301653A (nl) * 1993-09-24 1995-04-18 X Flow Bv Werkwijze voor het verwijderen van troebelheid veroorzakende bestanddelen uit een vloeistof met behulp van microfiltratie.
US6984379B1 (en) * 1994-04-08 2006-01-10 Children's Hospital of LosAngeles Gene therapy by administration of genetically engineered CD34+ cells obtained from cord blood
US5843780A (en) * 1995-01-20 1998-12-01 Wisconsin Alumni Research Foundation Primate embryonic stem cells
US6140040A (en) * 1995-10-06 2000-10-31 Advanced Minerals Corporation Method of mechanically separating microparticles suspended in fluids using particulate media
EP0874683A1 (en) * 1995-10-23 1998-11-04 Hemasure, Inc. Extra-lumenal crossflow plasmapheresis devices
US7002027B1 (en) * 1996-01-08 2006-02-21 Canji, Inc. Compositions and methods for therapeutic use
JP2001500753A (ja) * 1996-08-26 2001-01-23 ヘマシュア，インク． 腫瘍細胞に汚染された幹細胞産物から腫瘍細胞を除去する方法
DE19650648A1 (de) * 1996-12-06 1998-06-10 Sartorius Gmbh Wickelmodul
US6183640B1 (en) * 1999-04-09 2001-02-06 Usf Filtration And Separations Group, Inc. Highly asymmetric anionic membranes
BR0012627A (pt) 1999-07-23 2002-04-09 Genentech Inc Processo para purificar o dna de plasmìdeo de células procarióticas mediante o emprego de filtração de fluxo tangencial
CN1298949A (zh) * 1999-12-07 2001-06-13 刘宏宇 一种由酵母菌(Pichia pastoris)制备人体血清白蛋白的方法
US6544506B2 (en) * 2000-01-05 2003-04-08 Yeda Research & Development Co. Ltd. Veto cells effective in preventing graft rejection and devoid of graft versus host potential
US6866783B2 (en) * 2000-03-07 2005-03-15 Mat Adsorption Technologies Gmbh & Co. Kg Module with membrane elements in cross-flow and in a dead-end arrangement
US6455306B1 (en) * 2000-06-09 2002-09-24 Transcyte, Inc. Transfusable oxygenating composition
JP4407996B2 (ja) * 2000-06-15 2010-02-03 サンデン株式会社 コイン払出装置
KR100809489B1 (ko) * 2001-10-10 2008-03-03 씨제이제일제당 (주) 사이클로옥시게나제-2의 저해제로서 선택성이 뛰어난4'-메탄설포닐-비페닐 유도체
EP2156879A3 (en) * 2001-10-11 2010-07-07 Aviva Biosciences Corporation Methods, compositions and automated systems for separating rare cells from fluid samples
JP2003320011A (ja) * 2002-04-30 2003-11-11 Olympus Optical Co Ltd 生体組織補填材、生体組織補填体、生体組織補填体の製造方法及び生体組織補填体の製造装置
CN1713951B (zh) * 2002-06-19 2010-05-26 西北生物治疗药物公司 切向流过滤设备和白细胞富集方法
ES2321939T3 (es) 2003-02-27 2009-06-15 Northwest Biotherapeutics, Inc. Generacion de celulas dendriticas a partir de celulas precursoras dendriticas monociticas con gm-csf en ausencia de citoquinas adicionales.

Also Published As

Publication number Publication date
CN1886498A (zh) 2006-12-27
EP1689855A4 (en) 2008-04-16
IL175530A0 (en) 2006-09-05
AU2004293794B2 (en) 2011-06-02
CN1886498B (zh) 2013-10-30
US20050189297A1 (en) 2005-09-01
RU2006122038A (ru) 2008-01-10
CA2546349C (en) 2015-07-07
TW200524647A (en) 2005-08-01
CN102321573A (zh) 2012-01-18
AU2004293794A1 (en) 2005-06-09
JP2011182803A (ja) 2011-09-22
TWI354572B (en) 2011-12-21
EP1689855A1 (en) 2006-08-16
CN102321573B (zh) 2015-01-14
WO2005052137A1 (en) 2005-06-09
JP2007512814A (ja) 2007-05-24
CA2546349A1 (en) 2005-06-09
KR20070055416A (ko) 2007-05-30
CR8414A (es) 2006-11-23
US7790039B2 (en) 2010-09-07
JP5343110B2 (ja) 2013-11-13
IL175530A (en) 2012-07-31
AR047043A1 (es) 2006-01-04

Similar Documents

Publication Publication Date Title
BRPI0416898A (pt) dispositivos de filtragem de fluxo tangencial e métodos para o enriquecimento de células-tronco
GB2441939A (en) Surgical membrane
EA200601231A1 (ru) Дефинитивная энтодерма
DE60313597D1 (de) Topische pharmazeutische zusammensetzungen mit proanthocyanidinen, glycyrrhetinic säure und telmesteine zur behandlung von dermatitis
BRPI0407397A (pt) Evento de algodão mon 88913 e composições e métodos para sua detecção
DE602005020269D1 (de) Verwendung von treprostinil zur behandlung von neuropathischen diabetischen fussgeschwüren
DE502005008971D1 (de) Substituierte 1,4,8-triazaspiroä4.5 decan-2-on-verbindungen zur behandlung von fettsucht
BRPI0202278B8 (pt) dispositivo para separar células originárias de tecido, processo para isolar células e kit para separar células originárias de tecido
EP1855719A4 (en) NEUTRALIZING MONOCLONAL ANTIBODIES TO CORONAVIRES IN CONNECTION WITH HEAVY ACUTE RESPIRATORY SYNDROME
EA200602099A1 (ru) Получение прегабалина и родственных соединений
WO2005000860A3 (en) Compositions and methods for treatment of disease with acetylated disaccharides
EA200601995A1 (ru) Pdx1-экспрессирующая энтодерма
BRPI0516105A (pt) composições de fator de crescimento derivado de plaqueta e métodos de uso destas
WO2005012337A3 (en) Antigenic peptides of sars coronavirus and uses thereof
BR0312764A (pt) Cardiomiócitos funcionais originados de células-tronco embrionárias humanas
MX2009005460A (es) (s)-n-estereoisomeros de analogos de 7,8-saturados-4,5-epoxi-morfi nano.
EA200900806A1 (ru) Способы увеличения количества и мобилизации гемопоэтических стволовых клеток
WO2004111081A3 (en) Antigenic peptides of sars coronavirus and uses thereof
CY1109366T1 (el) Υποκατεστημενες ενωσεις 1,4,8-τριαζασπειρο[4.5]δεκαν-2-ονης
WO2003016464A3 (en) Cancer specific oligosaccharide sequences and use thereof
WO2008011387A3 (en) Preparation of a red blood cell component for a hematology control
BRPI0509302A (pt) método de purificação de oócitos de uma composição que compreende material fecal
BR0114595A (pt) Uso de um composto que rompe esteróide sexual que sinaliza para o timo no tratamento de um distúrbio de células t
DE602004001627D1 (de) Methode zur Racemisierung von (S)-(+)- und (R)-(-)-10,11-Dihydro-10-hydroxy-5H-dibenzib,föazepine-5-carboxamiden und optisch angereicherten Mischungen davon
BR0205439B1 (pt) método para concentração e recuperação de patógenos a partir de um fluido e circuito de fluido descartável para uso no mesmo.

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B08L Patent application lapsed because of non payment of annual fee [chapter 8.12 patent gazette]

Free format text: REFERENTE AO NAO RECOLHIMENTO DAS 8A E 9A ANUIDADES.

B08I Publication cancelled [chapter 8.9 patent gazette]

Free format text: ANULADA A PUBLICACAO CODIGO 8.12 NA RPI NO 2259 DE 22/04/2014 POR TER SIDO INDEVIDA.

B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE AS 8A, 9A, 10A, 11A, 12A, 13A, 14A E 15A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2602 DE 17-11-2020 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.